ArticleSisli Etfal Hastanesi tip bulteni2024
Pseudobulbar Affect Correlates with Mood Symptoms and Low Quality of Life in Patients with Parkinson's Disease: A Comprehensive Cross-Sectional Study.
Article in Sisli Etfal Hastanesi tip bulteni, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Despite being recognized for a long time as a characteristic of Parkinson's disease (PD), pseudobulbar affect (PBA) is still a symptom that is underdiagnosed and undertreated. This study aimed to assess the association between PBA and various mood disturbances, as well as the impact on quality of life in PD patients. Methods: Sixty-eight patients with PD were enrolled in this study. Their demographic and clinical features, including age, gender, education, smoking, lateralization and duration of the disease, and comorbidity, were recorded. The scores on the Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn-Yahr Scale, The Mental Component Summary (MCS-12), the Physical Component Summary (PCS-12), The Montreal Cognitive Assessment, and Beck Depression Inventory were evaluated. The Center for Neurologic Study-Lability Scale (CNS-LS) was used to explore PBA. Results: There were 12 patients (17%) with CNS-LS scores of ≥13, and 4 patients (5%) with CNS-LS scores of ≥4. BDI scores demonstrated a strong positive correlation with CNS-LS scores (Spearman correlation coefficient=0.64, p<0.001), and MCS-12 scores showed a significant negative correlation with CNS-LS scores (Spearman correlation coefficient=-0.70, p<0.001). The multivariate linear regression analysis showed that lower MCS-12 scores are related to higher CNS-LS scores, and higher BDI scores are also linked to higher CNS-LS scores. Conclusion: Our results indicate that elevated depressive symptoms correspond with increased CNS-LS scores, while a lower quality of mental health is also linked to higher CNS-LS scores. These findings highlight the influence of mood and mental health status on PDA among patients with PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.